Skip Navigation

Vaccine Safety Bibliography - September 2012

1.    Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Aug 31; 61:671-7.

2.   Centers for Disease Control and Prevention (CDC). Vaccination coverage among  children in kindergarten - United States, 2011-12 school year. MMWR Morb Mortal Wkly Rep. 2012 Aug 24; 61:647-52.

3.   Centers for Disease Control and Prevention (CDC). Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2012-13 Influenza Season. MMWR Morb Mortal Wkly Rep. 2012 Aug 17; 61:613-8.

4.   NewsCAP: Girls with health insurance aren't completing the three doses of the  human papillomavirus (HPV) vaccine needed for full protection. Am J Nurs. 2012 Aug; 112(8):17.

5.   Aaby P, Ravn H, Roth A, Rodrigues A, Lisse IM, Diness BR, Lausch KR, Lund N, Rasmussen J, Biering-Sørensen S, Whittle H, Benn CS. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality  and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child. 2012 Aug; 97(8):685-91.

6.   Adachi K, Coleman MS, de la Motte Hurst C, Vargas ML, Oladele A, Weinberg MS.  Costs of, and reimbursement for, vaccines: A case study at the Board of Health Refugee Services in DeKalb county, Georgia. Vaccine. 2012 Aug 18. [Epub ahead of print].

7.   Ahlers-Schmidt CR, Chesser AK, Nguyen T, Brannon J, Hart TA, Williams KS, Wittler RR. Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs). Vaccine. 2012 Aug 3; 30(36):5305-9.

8.   Amanna IJ, Hammarlund E, Lewis MW, Slifka MK. Impact of infection or vaccination on pre-existing serological memory. Hum Immunol. 2012 Aug 16. [Epub ahead of print].

9.   Aoun B, Dourthe ME, Davourie Salandre A, Souberbielle JC, Ulinski T. Do vitamin D plasma levels impact vaccine response in children with idiopathic nephrotic syndrome? Pediatr Nephrol. 2012 Aug 16. [Epub ahead of print].

10.  Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, Bhuiyan MS, Rahman MA, Khanam F, Saha A, Charles RC, Larocque RC, Weil AA, Clements JD, Holmes RK, Calderwood SB, Harris JB, Ryan ET, Qadri F. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2012 Aug; 19(8):1304-11.

11.   Artenstein AW, Poland GA. Vaccine history: The past as prelude to the future. Vaccine. 2012 Aug 3; 30(36):5299-301.

12.   Aspinall S, Traynor D, Bedford P, Hartmann K. Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem (®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine. Hum Vaccin Immunother. 2012 Aug 1; 8(8). [Epub ahead of print].

13.  Atrasheuskaya A, Kulak M, Fisenko EG, Karpov I, Ignatyev G, Atrasheuskaya A.  Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: A report of six symptomatic cases of parotitis and one case of meningitis. Vaccine. 2012 Aug 3; 30(36):5324-6.

14.  Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis. 2012 Aug; 25(4):464-8.

15.  Babji S, Kang G. Rotavirus vaccination in developing countries. Curr Opin Virol. 2012 Aug; 2(4):443-8.

16.  Baldovin T, Mel R, Bertoncello C, Carpenè G, Soppelsa F, Giliberti A, Baldo V. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection. J Med Virol. 2012 Aug; 84(8):1274-8.

17.  Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson MA, Lal RB, Koul PA. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India. Influenza Other Respi Viruses. 2012 Aug 2. [Epub ahead of print].

18.  Barbosa CM, Terreri MT, Rosario PO, de Moraes-Pinto MI, Silva CA, Hilario MO. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol. 2012 Aug 30. [Epub ahead of print].

19.  Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing vaccine antigen pertactin in Finland. Clin Vaccine Immunol. 2012 Aug 22. [Epub ahead of print].

20.  Bechini A, Levi M, Boccalini S, Tiscione E, Balocchini E, Canessa C, Azzari C, Bonanni P. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy. Vaccine. 2012 Aug 23. [Epub ahead of print].

21.  Bedognetti D, Ansaldi F, Zanardi E, Durando P, Sertoli MR, Massucco C, Balleari E, Racchi O, Zoppoli G, Orsi A, Alicino C, Icardi G, Marincola FM, Zupo  S, Ferrarini M, De Maria A. Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted  influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. Blood. 2012 Aug 30; 120(9):1954-1957.  

22.  Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012 Aug 30. [Epub ahead of print].

23.  Betsch C, Renkewitz F, Haase N. Effect of Narrative Reports about Vaccine Adverse Events and Bias-Awareness Disclaimers on Vaccine Decisions: A Simulation  of an Online Patient Social Network. Med Decis Making. 2012 Aug 8. [Epub ahead of print].

24.  Bielicki JA, Achermann R, Berger C. Timing of measles immunization and effective population vaccine coverage. Pediatrics. 2012 Sep; 130(3):e600-6.

25.  Birdwell KA, Ikizler MR, Wang L, Byrne DW, Sannella EC, Wright PF, Ikizler TA. Seasonal Maintenance of Influenza Vaccine-Induced Antibody Response in Kidney Transplant Recipients. Am J Nephrol. 2012 Aug 17; 36(3):201-207. [Epub ahead of print].

26.  Blaizeau F, Lasserre A, Rossignol L, Blanchon T, Kernéis S, Hanslik T, Levy-Bruhl D. Practices of French family physicians concerning varicella vaccination for teenagers. Med Mal Infect. 2012 Aug 29. [Epub ahead of print].

27.  Bliu A, Lemieux M, Li C, Li X, Wang J, Farnsworth A. Modifying the thermostability of inactivated influenza vaccines. Vaccine. 2012 Aug 10; 30(37):5506-11.

28.  Blomqvist S, El Bassioni L, El Maamoon Nasr EM, Paananen A, Kaijalainen S, Asghar H, de Gourville E, Roivainen M. Detection of imported wild polioviruses and of vaccine-derived polioviruses by environmental surveillance in egypt. Appl  Environ Microbiol. 2012 Aug; 78(15):5406-9.

29.  Blondel B, Mahjoub N, Drewniak N, Launay O, Goffinet F. Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: Results from a national survey. Vaccine. 2012 Aug 17; 30(38):5661-5.

30.  Bonhoeffer J, Black S, Izurieta H, Zuber P, Sturkenboom M. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals. 2012 Sep; 40(5):393-7.

31.  Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ. Symptomatic infection and detection of vaccine and vaccine reassortant rotavirus strains in 5 children: A case series. J Infect Dis. 2012 Aug 7. [Epub ahead of print].

32.  Braeckman T, Van Herck K, Meyer N, Pirçon JY, Soriano-Gabarró M, Heylen E, Zeller M, Azou M, Capiau H, De Koster J, Maernoudt AS, Raes M, Verdonck L, Verghote M, Vergison A, Matthijnssens J, Van Ranst M, Van Damme P; on behalf of the RotaBel Study Group. Effectiveness of rotavirus vaccination in prevention of  hospital admissions for rotavirus gastroenteritis among young children in Belgium: case control study. BMJ. 2012 Aug 8; 345:e4752.

33.  Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, Macneil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE. Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998-2009. Pediatrics. 2012 Sep; 130(3):414-20.

34.  Brigham KS, Woods ER, Steltz SK, Sandora TJ, Blood EA. Randomized controlled  trial of an immunization recall intervention for adolescents. Pediatrics. 2012 Sep; 130(3):507-14.

35.  Bryant K, McVernon J, Marchant C, Nolan T, Marshall G, Richmond P, Marshall H, Nissen M, Lambert S, Aris E, Mesaros N, Miller J. Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: A pooled analysis of randomized trials. Hum Vaccin Immunother. 2012 Aug 1; 8(8). [Epub ahead of print].

36.  Bucardo F, Rippinger CM, Svensson L, Patton JT. Vaccine-derived NSP2 segment  in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol. 2012 Aug; 12(6):1282-94.

37.  Buttenheim A, Jones M, Baras Y. Exposure of california kindergartners to students with personal belief exemptions from mandated school entry vaccinations. Am J Public Health. 2012 Aug; 102(8):e59-67.

38.  Campos-Outcalt D. Meningococcal vaccine for infants? J Fam Pract. 2012 Aug; 61(8):482-4.

39.  Cardoso CW, Pinto LL, Reis MG, Flannery B, Reis JN. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil. Vaccine. 2012 Aug 10; 30(37):5541-6.

40.  Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ, Tegzová D, McKay JD, Avila-Armengol HE, Utset TO, Zhong ZJ, Hough DR, Freimuth WW, Migone TS; on behalf of the BLISS-76 Study Group. Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial. J Rheumatol. 2012 Aug; 39(8):1632-1640.

41.  Cherry JD. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. N Engl J Med. 2012 Aug 30; 367(9):785-7.

42.  Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A, Picaud H. Treatment with the interleukin-17A blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: Results of an open-label, parallel-group, randomized single-center study.  Clin Vaccine Immunol. 2012 Aug 8. [Epub ahead of print]. 

43.  Cho BH, Beeler Asay GR, Lorick SA, Tipton ML, Dube NL, Messonnier ML. Costs of School-Located Influenza Vaccination Clinics in Maine During the 2009-2010 H1N1 Pandemic. J Sch Nurs. 2012 Aug 22. [Epub ahead of print].

44.  Clifford HD, Hayden CM, Khoo SK, Naniche D, Mandomando IM, Zhang G, Richmond  P, Le Souëf PN. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine. 2012 Aug 4. [Epub ahead of print].

45.  Cohen AL, Taylor T Jr, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United  States. PLoS One. 2012; 7(8):e41785.

46.  Cohen R, Levy C, Bingen E, Bechet S, Derkx V, Werner A, Koskas M, Varon E. [Nasopharyngeal carriage of children 6 to 60 months during the implementation of  the 13-valent pneumococcal conjugate vaccine.]. Arch Pediatr. 2012 Aug 24. [Epub ahead of print].

47.  Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V,  McNeil SA. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine. 2012 Aug 16. [Epub ahead of print].

48.  Connolly MP, Topachevskyi O, Standaert B, Ortega O, Postma M. The impact of rotavirus vaccination on discounted net tax revenue in egypt: a government perspective analysis. Pharmacoeconomics. 2012 Aug 1; 30(8):681-95.

49.  Cover JK, Nghi NQ, Lamontagne DS, Huyen DT, Hien NT, Nga LT. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health. 2012 Aug 9; 12(1):629. [Epub ahead of print].

50.  Cummings T, Zimet GD, Brown D, Tu W, Yang Z, Fortenberry JD, Shew ML. Reduction of HPV infections through vaccination among at-risk urban adolescents.  Vaccine. 2012 Aug 10; 30(37):5496-9.

51.  Dagnew AF, Hussein J, Abebe M, Zewdie M, Mihret A, Bedru A, Chanyalew M, Yamuah L, Medhin G, Bang P, Doherty TM, Hailu A, Aseffa A. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC Res Notes. 2012 Aug 7; 5(1):415. [Epub ahead of print].

52.  Dbaibo G, Van der Wielen M, Reda M, Medlej F, Tabet C, Boutriau D, Sumbul A,  Anis S, Miller JM. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine. Int J Infect Dis. 2012 Aug; 16(8):e608-15.

53. De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, Guillemette F, Soto J, Ouakki M, Ward BJ, Skowronski DM. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age. Clin Infect Dis. 2012 Aug; 55(3):394-402.

54.  De Wals P, Lefebvre B, Defay F, Deceuninck G, Boulianne N. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine. 2012 Aug 21. [Epub ahead of print].

55.  Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Shane A, Zhanel GG, Tyrrell GJ, Gilmour MW, Toronto Invasive Bacterial Diseases Network, Canadian Public Health Laboratory Network. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010. Can J Microbiol. 2012 Aug; 58(8):1008-17.

56.  Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD. Potential Intussusception Risk versus Benefits of Rotavirus Vaccination in the United States. Pediatr Infect Dis J. 2012 Aug 27. [Epub ahead  of print].

57.  Dolan GP, Harris RC, Clarkson M, Sokal R, Morgan G, Mukaigawara M, Horiuchi H, Hale R, Stormont L, Béchard-Evans L, Chao YS, Eremin S, Martins S, Tam JS, Peñalver J, Zanuzadana A, Nguyen-Van-Tam JS. Vaccination of health care workers to protect patients at increased risk for acute respiratory disease. Emerg Infect Dis. 2012 Aug; 18(8):1225-34.

58.  Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Martín V, Saez M, Soldevila N, Quintana JM, Mayoral JM, Astray J, González-Candelas F, Cantón R, Tamames S, Castro A, Baricot M, Alonso J, Pumarola T; the CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization. Vaccine. 2012 Aug 17; 30(38):5644-5650.

59. Donato CM, Ch'ng LS, Boniface KF, Crawford NW, Buttery JP, Lyon M, Bishop RF, Kirkwood CD. Identification of Strains of RotaTeq Rotavirus Vaccine in Infants With Gastroenteritis Following Routine Vaccination. J Infect Dis. 2012 Aug; 206(3):377-83.

60. Dubé E, Bettinger JA, Halperin B, Bradet R, Lavoie F, Sauvageau C, Gilca V, Boulianne N. Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study. Health Educ Res. 2012 Aug 20. [Epub ahead of print].

61.  Duraisingham SS, Rouphael N, Cavanagh MM, Nakaya HI, Goronzy JJ, Pulendran B. Systems Biology of Vaccination in the Elderly. Curr Top Microbiol Immunol. 2012 Aug 18. [Epub ahead of print].

62.  Edwards KM, Pung MA, Tomfohr LM, Ziegler MG, Campbell JP, Drayson MT, Mills PJ. Acute exercise enhancement of pneumococcal vaccination response: A randomized controlled trial of weaker and stronger immune response. Vaccine. 2012 Aug 22. [Epub ahead of print].

63.  Enserink M. Public health. Policy shifts on emergency use of cholera vaccines. Science. 2012 Aug 17; 337(6096):785-6.

 64.  Eppes C, Wu A, Cameron KA, Garcia P, Grobman W. Does obstetrician knowledge regarding influenza increase HINI vaccine acceptance among their pregnant patients? Vaccine. 2012 Aug 24; 30(39):5782-4.

65.  Espinosa-Padilla SE, Murata C, Estrada-Parra S, Santos-Argumedo L, Mascareñas C, Franco-Paredes C, Espinosa-Rosales FJ. Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine Among Mexican Children. Arch Med Res. 2012 Aug 3. [Epub ahead of print]. 

66.  Estes MK, Desselberger U. Rotaviruses: cause of vaccine-preventable disease yet many fundamental questions remain to be explored. Curr Opin Virol. 2012 Aug;2(4):369-72.

 67.  Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini FS. Novel Health Economic Evaluation of a Vaccination Strategy to Prevent HPV-related Diseases: The BEST Study. Med Care. 2012 Aug 23. [Epub ahead of print].

 68.  Ferri C, Colaci M, Manzini CU, Sebastiani M, Giuggioli D, Brugioni L. Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines. Case Report Rheumatol. 2012; 2012:836930.

 69.  Flatt A, Breuer J. Varicella vaccines. Br Med Bull. 2012;103:115-27.  

 70.  Forstner C, Plefka S, Tobudic S, Winkler HM, Burgmann K, Burgmann H. Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients. Vaccine. 2012 Aug 10; 30(37):5449-52. 

71.  França IL, Ribeiro AC, Aikawa NE, Saad CG, Moraes JC, Goldstein-Schainberg C, Laurindo IM, Precioso AR, Ishida MA, Sartori AM, Silva CA, Bonfa E. TNF blockers  show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. Rheumatology (Oxford). 2012 Aug 20. [Epub ahead of print].

72.  Frenck RW Jr, Gurtman A, Rubino J, Smith W, van Cleeff M, Jayawardene D, Giardina PC, Emini EA, Gruber WC, Scott DA, Schmöle-Thoma B. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol.  2012 Aug; 19(8):1296-303.

73.  Frickmann H, Scherpe S, Schweiger B, Wählisch S, Reuter K, Bronnert J. Despite triple vaccination. J Clin Virol. 2012 Aug; 54(4):291-4.

74.  Friedman D Phd. Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults. J Infect Dis. 2012 Aug 13. [Epub ahead of print].

75.  Fujii K, Suyama M, Chiba K, Okunushi T, Oikawa J, Kohno Y. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine. Pediatr Int. 2012 Aug;54(4):539-41.

76.  Furlow-Parmley C, Singleton JA, Bardenheier B, Bryan L. Combining estimates from two surveys: An example from monitoring 2009 influenza A (H1N1) pandemic vaccination. Stat Med. 2012 Aug 1. [Epub ahead of print].

 77.  Gainforth HL, Cao W, Latimer-Cheung AE. Determinants of Human Papillomavirus  (HPV) Vaccination Intent Among Three Canadian Target Groups. J Cancer Educ. 2012  Aug 4. [Epub ahead of print].

 78. Geldenhuys H, Waggie Z, Jacks M, Geldenhuys M, Traut L, Tameris M, Hatherill M, Hanekom WA, Sutter R, Hussey G, Mahomed H. Vaccine trials in the developing world: Operational lessons learnt from a phase IV poliomyelitis vaccine trial in  South Africa. Vaccine. 2012 Aug 31;30(40):5839-43.

 79.  Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing AdvaxTM polysaccharide adjuvant. Vaccine. 2012 Aug 3; 30(36):5407-16.

 80.  Griffiths UK, Clark A, Gessner B, Miners A, Sanderson C, Sedyaningsih ER, Mulholland KE. Dose-specific efficacy of Haemophilus influenzae type b conjugate  vaccines: a systematic review and meta-analysis of controlled clinical trials. Epidemiol Infect. 2012 Aug; 140(8):1343-55.

 81.  Gruber WC, Scott DA, Emini EA. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM(197) conjugate vaccine. Ann N Y Acad Sci. 2012 Aug; 1263(1):15-26.

 82.  Gualberto FA, Curti SP, Oliveira MI, Moraes-Vasconcelos D, Figueiredo CA. Intermittent rash, lymph node swelling, arthralgia and vaccinal viral detection after rubella immunization. J Clin Virol. 2012 Aug 16. [Epub ahead of print].

83.  Guiso N. Specific Biological Diagnoses Are Needed to Determine the Durability of Pertussis Vaccine-Induced Immunity. Clin Infect Dis. 2012 Aug 31. [Epub ahead of print].

 84.  Guissa VR, Pereira RM, Sallum AM, Aikawa NE, Campos LM, Silva CA, Bonfá E. Influenza A H1N1/2009 vaccine in juvenile dermatomyositis: reduced immunogenicity in patients under immunosuppressive therapy. Clin Exp Rheumatol. 2012 Jul-Aug;30(4):583-8. Epub 2012 Aug 29. PubMed PMID:

 85.  Gutierrez B Jr, Leung A, Jones KT, Smith P, Silverman R, Frank I, Leader AE. Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males. Am J Mens Health. 2012 Aug 14. [Epub ahead of print].

 86.  Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C; the Causality Working Group of the Clinical Immunization Safety Assessment network. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24; 30(39):5791-5798.

 87.  Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012 Aug 1; 90(8):568-77.

 88.  Hanley SJ, Yoshioka E, Ito Y, Konno R, Hayashi Y, Kishi R, Sakuragi N. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese  mothers of adolescent girls. Vaccine. 2012 Aug 24; 30(39):5740-7. 

89.  Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012 Aug 15; 8:CD007072.

 90.  Hawkins J, Kodali S, Matsuka YV, McNeil LK, Mininni T, Scully IL, Vernachio  JH, Severina E, Girgenti D, Jansen KU, Anderson AS, Donald RG. A recombinant Clumping factor A containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure. Clin Vaccine  Immunol. 2012 Aug 15. [Epub ahead of print].

91.  Hayashi Y, Shimizu Y, Netsu S, Hanley S, Konno R. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan. Vaccine. 2012 Aug 10; 30(37):5547-50. 

92.  Hechter RC, Chao C, Jacobsen SJ, Slezak JM, Quinn VP, Van Den Eeden SK, Tseng HF. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.

93.  Hendriks J. Technology transfer in human vaccinology: A retrospective review on public sector contributions in a privatizing science field. Vaccine. 2012 Aug  14. [Epub ahead of print].

94.  Hernandez-Bou S, Garcia-Garcia JJ, Gene A, Esteva C, Del Amo E, Muñoz-Almagro C. Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona. Diagn Microbiol Infect Dis. 2012 Aug 23. [Epub ahead of print].

95.  Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R,  Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, Laforce FM. Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: A Phase II/III double-blind randomized controlled trial. Vaccine. 2012 Aug 13. [Epub ahead of print].

96.  Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. Int J Infect Dis. 2012 Aug; 16(8):e621-7.

97.  Hulbert-Powell E, Pérez-Gaxiola G. Review: flu vaccines provide a moderate risk reduction in healthy children. Arch Dis Child Educ Pract Ed. 2012 Aug; 97(4):164.

98.  Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong TY, Yuen  KY. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine. 2012 Aug 18. [Epub ahead of print].

99.  Hunt C, Arthur A. Student nurses' reasons behind the decision to receive or  decline influenza vaccine: A cross-sectional survey. Vaccine. 2012 Aug 31; 30(40):5824-9.

100. Hutchinson E. Vaccination: Oral vaccine induces genitorectal immunity. Nat Rev Drug Discov. 2012 Aug 31; 11(9):673.

101.  Hutchinson E. Vaccination: Oral vaccine induces genitorectal immunity. Nat Rev Immunol. 2012 Aug 10; 12(9):619.

102. Igari H, Watanabe A, Segawa S, Suzuki A, Watanabe M, Sakurai T, Watanabe M,  Tatsumi K, Nakayama M, Suzuki K, Sato T. Immunogenicity of a Monovalent A/H1pdm Vaccine with or without prior Seasonal Influenza Vaccine Administration. Clin Vaccine Immunol. 2012 Aug 1. [Epub ahead of print].

103.  Ikematsu H, Tenjinbaru K, Li P, Madan A, Vaughn D. Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 y of age or older. Hum Vaccin Immunother. 2012 Aug 1; 8(8). [Epub ahead of print].

104.  Ishola DA Jr, Borrow R, Findlow H, Findlow J, Trotter C, Ramsay ME. Prevalence of Serum Bactericidal Antibody to Serogroup C Neisseria meningitides in England a Decade after Vaccine Introduction. Clin Vaccine Immunol. 2012 Aug; 19(8):1126-30.

105.  Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012 Aug 15; 8:CD004879.

106. Jenke AC, Klein S, Baiker A, Wirth S, Sander M, Noelting C, Boecher O, Vizoso-Pinto MG. Serologic Analysis of the IgG Antibody Response in Children with Varicella Zoster Virus Wild Type Infection and Vaccination. Pediatr Infect Dis J. 2012 Aug 3. [Epub ahead of print].

107. Jessop AB, Dumas H, Moser CA. Delivering Influenza Vaccine to High-Risk Adults: Subspecialty Physician Practices. Am J Med Qual. 2012 Aug 28. [Epub ahead of print]. 

108. Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein DI. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics. 2012 Aug; 130(2):e249-56. 

109. Karras NA, Weeres M, Sessions W, Xu X, Defor T, Young JA, Stefanski H, Brunstein C, Cooley S, Miller JS, Blazar BR, Wagner JE, Verneris MR. A Randomized Trial of One vs. Two Doses of Influenza Vaccine Following Allogeneic Transplantation. Biol Blood Marrow Transplant. 2012 Aug 29. [Epub ahead of print].

110. Katz ML, Kam JA, Krieger JL, Roberto AJ. Predicting Human Papillomavirus Vaccine Intentions of College-Aged Males: An Examination of Parents' and Son's Perceptions. J Am Coll Health. 2012 Aug; 60(6):449-59.

111. Kelminson K, Saville A, Seewald L, Stokley S, Dickinson LM, Daley MF, Suh C, Kempe A. Parental views of school-located delivery of adolescent vaccines. J Adolesc Health. 2012 Aug;51(2):190-6.

112. Kelso JM. Safety of influenza vaccines. Curr Opin Allergy Clin Immunol. 2012 Aug; 12(4):383-8.

113. Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Johnson DR, Borrow R. Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian 5-8 year old children previously vaccinated with 2 doses of a meningococcal quadrivalent polysaccharide vaccine. Clin Vaccine Immunol. 2012 Aug 1. [Epub ahead of print]

114. Kim HW. Knowledge about human papillomavirus (HPV), and health beliefs and intention to recommend HPV vaccination for girls and boys among Korean health teachers. Vaccine. 2012 Aug 3; 30(36):5327-34.

115. Klepac P, Bjørnstad ON, Metcalf CJ, Grenfell BT. Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination. PLoS One. 2012;7(8):e41428.

116. Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W, Cox N; Writing Committee of the World Health Organization Consultation on Southern Hemisphere Influenza Vaccine Composition for 2012. WHO recommendations for the viruses to be used in the 2012  Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Aug 20. [Epub ahead of print].

117. Knezevic I, Griffiths E, Petricciani J, Bramley D. The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines. Biologicals. 2012 Aug 15. [Epub ahead of print].

118. Korosec P, Petrovec M, Lainscak M, Meško P, Silar M, Kosnik M. High Nonspecific T Lymphocyte Response to the Adjuvanted H1N1 Vaccine in Comparison to the H1N1/H3N2/B-Brisbane Vaccine without Adjuvant. Scand J Immunol. 2012 Aug 4. [Epub ahead of print].

119. Kumagai T, Kiyono H. Summary for Symposium I on the Development of a More Efficacious Influenza Vaccine Held at the 15th Annual Meeting of the Japanese Society for Vaccinology, Tokyo, 2011. Vaccine. 2012 Aug 18. [Epub ahead of print].

120. Källén B, Olausson P. Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study. BJOG. 2012 Aug 20. [Epub ahead of print].

121. Lachiany M, Stone L. A Vaccination Model for a Multi-City System. Bull Math  Biol. 2012 Aug 18. [Epub ahead of print].

122. Langley JM, Reich D, Aggarwal N, Connor D, Lebel MH, Gupta A, Garfield H, Li P, Madan A, Vaughn DW. Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children  6 Months to <9 Years of Age: Safety and Immunogenicity. Pediatr Infect Dis J. 2012 Aug; 31(8):848-858.

123. Lederman ER, Davidson W, Groff HL, Smith SK, Warkentien T, Li Y, Wilkins KA, Karem KL, Akondy RS, Ahmed R, Frace M, Shieh WJ, Zaki S, Hruby DE, Painter WP, Bergman KL, Cohen JI, Damon IK. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246 and CMX001. J Infect Dis. 2012 Aug 16. [Epub ahead of print].

124. Lee BR, Ayres EJ. APhA's Immunization Handbook, 2nd Edition. Ann Pharmacother. 2012 Aug 21. [Epub ahead of print].

125. Lee BY, Cakouros BE, Assi TM, Connor DL, Welling J, Kone S, Djibo A, Wateska AR, Pierre L, Brown ST. The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine. 2012 Aug 17; 30(38):5637-43.

126. Lehtinen M. Cross-protection is crucial for prophylactic HPV vaccination. Lancet Infect Dis. 2012 Aug 21. [Epub ahead of print].

127. Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapelière P, Vassilev V, Ledent E, Heineman TC. A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults. J Infect Dis. 2012 Aug 21. [Epub ahead of print].

128. Levin MJ. Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol. 2012 Aug; 24(4):494-500.

129. Li S, Zhu J. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination? Vaccine. 2012 Aug 17; 30(38):5585.

130. Liu Q, Ertl HC. Preventative childhood vaccination to rabies. Expert Opin Biol Ther. 2012 Aug;12(8):1067-75.

131. Loerbroks A, Stock C, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health. 2012 Aug;22(4):562-8.

132. Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Curr Opin Virol. 2012 Aug;2(4):434-42.

133. Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M,  Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One. 2012; 7(8):e41720.

134. Louik C, Chambers C, Jacobs D, Rice F, Johnson D, Mitchell AA. Influenza vaccine safety in pregnancy: can we identify exposures? Pharmacoepidemiol Drug Saf. 2012 Aug 17.  [Epub ahead of print].

135. Mahamud A, Wiseman R, Grytdal S, Basham C, Asghar J, Dang T, Leung J, Lopez  A, Schmid DS, Bialek SR. Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine. 2012 Aug 7. [Epub ahead of print].

136. Maltezou HC, Kalogriopoulou K, Pergialiotis V, Siahanidou T, Skiathitou AV,  Katerelos P, Goumalatsos N, Kostis E, Antsaklis A, Theodoridou M. Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece. Vaccine. 2012 Aug 31; 30(40):5871-4.

137. Mameli C, Fabiano V, Zuccotti GV. New insights into rotavirus vaccines. Hum  Vaccin Immunother. 2012 Aug 1; 8(8). [Epub ahead of print].

138. Mannino S, Villa M, Apolone G, Weiss NS, Groth N, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Rothman K. Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy. Am J Epidemiol. 2012 Aug 31. [Epub ahead of print].

139. Mariotti J, Spina F, Carniti C, Anselmi G, Lucini D, Vendramin A, Pregliasco F, Corradini P. Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies. Eur J Haematol. 2012 Aug;89(2):111-9.

140. Martínez Martínez F, Sequí Canet A, Lluch Rodrigo JA, Pastor Villalba E. [Influenza vaccination cover by health care levels in a health department: Periods 2006-2007 to 2010-2011]. Aten Primaria. 2012 Aug;44(8):e21-2.

141. Mayor S. Advertising watchdog orders website to remove claims linking MMR vaccine with autism. BMJ. 2012 Aug 9; 345:e5420.

142. McCarthy EA, Pollock WE, Nolan T, Hay S, McDonald S. Improving influenza vaccination coverage in pregnancy in Melbourne 2010-2011. Aust N Z J Obstet Gynaecol. 2012 Aug; 52(4):334-41.

143. McCarthy EM, Azeez MA, Fitzpatrick FM, Donnelly S. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population. J Clin Rheumatol. 2012 Aug; 18(5):237-41.

144. McCauley MM, Kennedy A, Basket M, Sheedy K. Exploring the Choice to Refuse or Delay Vaccines: A National Survey of Parents of 6- Through 23-Month-Olds. Acad Pediatr. 2012 Aug 22. [Epub ahead of print].

145. Melo Gomes S, Glover M, Malone M, Brogan P. Vasculitis following HPV immunization. Rheumatology (Oxford). 2012 Aug 9. [Epub ahead of print].

146. Minor PD. Polio vaccines and the eradication of poliomyelitis. Lancet. 2012  Aug 4;380(9840):454-5.

147. Misegades LK, Martin SW, Messonnier NE, Clark TA. Estimating the Effectiveness of Acellular Pertussis Vaccines. Clin Infect Dis. 2012 Aug 31. [Epub ahead of print].

148. Mohammadi D. The final push for polio eradication? Lancet. 2012 Aug 4; 380(9840):460-2.

149. Mollers M, Scherpenisse M, van der Klis FR, King AJ, van Rossum TG, van Logchem EM, Feltkamp MC, Meijer CJ, Snijders PJ, Boot HJ, de Melker HE. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior  to vaccination. Cancer Epidemiol. 2012 Aug 17. [Epub ahead of print].

150. Mori S, Ueki Y, Hirakata N, Oribe M, Hidaka T, Oishi K. Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis. 2012 Aug 11. [Epub ahead of print].

151. Morin A, Lemaître T, Farrands A, Carrier N, Gagneur A. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Vaccine. 2012 Sep 7; 30(41):5921-7.

152. Morin MP, Quach C, Fortin E, Chédeville G. Vaccination coverage in children  with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford). 2012 Aug 3. [Epub ahead of print].

153. Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two. Vaccine. 2012 Aug 10. [Epub ahead of print].

154. Mosca A, Leblanc A, Bellaïche M, Tounian P, Cohen R. [How many deaths before rotavirus vaccination becomes routine?]. Arch Pediatr. 2012 Aug; 19(8):783-5.

155. Moukarram H, Nargund A, Photiou A, Kiran TS. Awareness and acceptance of the pandemic influenza (H1N1v 2009) vaccination among antenatal patients in a district general hospital. J Obstet Gynaecol. 2012 Aug; 32(6):537-9.

156. Mourão LC, Morais CG, Bueno LL, Jimenez MC, Soares IS, Fontes CJ, Guimarães  Lacerda MV, Xavier MS, Barnwell JW, Galinski MR, Braga EM. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1©û₉ and PvMSP-3α©ý₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon. Microbes Infect. 2012 Aug; 14(9):730-9.

157. Mousavi-Jazi M, Karlberg H, Papa A, Christova I, Mirazimi A. Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. Vaccine. 2012 Aug 14. [Epub ahead of print].

158. Naleway A, Gold R, Henninger M, Kurosky S, Riedlinger K, Nordin J, Kharbanda E, Weintraub E. CA5-04: Identifying Pregnancy Episodes in the Vaccine Safety Datalink. Clin Med Res. 2012 Aug; 10(3):179.

159. Neu AM. Immunizations in children with chronic kidney disease. Pediatr Nephrol. 2012 Aug;27(8):1257-63.

160. Newall AT, Dehollain JP, Wood JG. Under-explored assumptions in influenza vaccination models: Implications for the universal vaccination of children. Vaccine. 2012 Aug 24;30(39):5776-81.

161. Newall AT, Jit M, Beutels P. Economic evaluations of childhood influenza vaccination: a critical review. Pharmacoeconomics. 2012 Aug 1; 30(8):647-60.

162. O'Reilly KM, Durry E, ul Islam O, Quddus A, Abid N, Mir TP, Tangermann RH, Aylward RB, Grassly NC. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet. 2012 Aug 4;380(9840):491-8.

163. Odutola AA, Owolabi OA, Owiafe PK, McShane H, Ota MO. A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants. Vaccine. 2012 Aug 17; 30(38):5591-4.

164. Orcurto A, Pascual M, Hoschler K, Aubert V, Meylan P, Manuel O. Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients. Transplantation. 2012 Aug 14. [Epub ahead of print].

165. Ortqvist A, Bennet R, Rinder MR, Lindblad H, Eriksson M. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza. Vaccine. 2012 Aug 24; 30(39):5699-702.

166. Ota MO, Roca A, Bottomley C, Hill PC, Egere U, Greenwood B, Adegbola RA. Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine. PLoS One. 2012;7(8):e42997.

167. Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell  R, Krumbholz A. Serological response to influenza A H1N1 vaccine (Pandemrix(®)) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. Med Microbiol Immunol. 2012 Aug;201(3):297-302.

168. Pakkanen SH, Kantele JM, Kantele A. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine. 2012 Sep 14; 30(42):6047-53.

169. Palmer KT, Cosgrove M. Vaccinating welders against pneumonia. Occup Environ  Med. 2012 Aug 23. [Epub ahead of print].

170. Panatto D, Amicizia D, Trucchi C, Casabona F, Lai PL, Bonanni P, Boccalini S, Bechini A, Tiscione E, Zotti CM, Coppola RC, Masia G, Meloni A, Castiglia P, Piana A, Gasparini R. Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future  vaccination policies. BMC Public Health. 2012 Aug 7; 12(1):623. [Epub ahead of print]

171. Patel MM. Rotavirus vaccination programmes. BMJ. 2012 Aug 8;345:e5286.

172. Patel SM, Atmar RL, El Sahly HM, Guo K, Hill H, Keitel WA. Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes. J Infect Dis. 2012 Aug 13. [Epub ahead of print].

173. Pathan AA, Minassian AM, Sander CR, Rowland R, Porter DW, Poulton ID, Hill AV, Fletcher HA, McShane H. Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults. Vaccine. 2012 Aug 17;30(38):5616-24.

174. Patrzalek M, Gorynski P, Albrecht P. Indirect population impact of universal PCV7 vaccination of children in a 2 + 1 schedule on the incidence of pneumonia morbidity in Kielce, Poland. Eur J Clin Microbiol Infect Dis. 2012 Aug 16. [Epub ahead of print].

175. Peeters M, Regner S, Vaman T, Devaster JM, Rombo L. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials. Vaccine. 2012 Aug 9. [Epub ahead of print].

176. Perkins RB, Apte G, Marquez C, Porter C, Belizaire M, Clark JA, Pierre-Joseph N. Factors Affecting Human Papillomavirus Vaccine Utilization among White, Black, and Latino Parents of Sons. Pediatr Infect Dis J. 2012 Aug 21. [Epub ahead of print].

177. Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody. J Immunol. 2012 Sep 1;189(5):2673-81.

178. Peters TR, Banks GC, Snively BM, Poehling KA. Potential impact of parental Tdap immunization on infant pertussis hospitalizations. Vaccine. 2012 Aug 10; 30(37):5527-32.

179. Petráš M, Sýkora T, Andrýs C, Drahošová M. Post-vaccination anti-human papillomavirus antibody seroprevalence among Czech teenaged girls and women. Int  J Gynaecol Obstet. 2012 Aug 17. [Epub ahead of print].

180. Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One. 2012;7(8):e42320.

181. Poland GA, Jacobson RM. The clinician's guide to the anti-vaccinationists' galaxy. Hum Immunol. 2012 Aug; 73(8):859-866.

182. Porat N, Benisty R, Trefler R, Givon-Lavi N, Dagan R. Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): Marked differences between two ethnic populations in southern Israel. J Clin Microbiol. 2012 Aug 8. [Epub ahead of print].

183. Priftis KN, Litt D, Manglani S, Anthracopoulos MB, Thickett K, Tzanakaki G,  Fenton P, Syrogiannopoulos GA, Vogiatzi A, Douros K, Slack M, Everard ML. Streptococcus pneumoniae and non-typable Haemophilus influenzae causing bacterial bronchitis in children and the impact of vaccination. Chest. 2012 Aug 13. [Epub ahead of print].

184. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Pérez-Vilar S, Micó-Esparza JL, Belenguer-Varea A, Carratalá-Munuera C, Gil-Guillén V, Schwarz-Chavarri H. Effectiveness of the 2010-2011 seasonal influenza vaccine in  preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study. Vaccine. 2012 Aug 24;30(39):5714-20.

185. Pérez O, Batista-Duharte A, González E, Zayas C, Balboa J, Cuello M, Cabrera O, Lastre M, Schijns VE. Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations. Braz J Med Biol Res. 2012 Aug; 45(8):681-92.

186. Qian L, Tseng HF, Sy LS, Jacobsen SJ. Confounder adjustment in vaccine safety studies: Comparing three offset terms for case-centered approach. Vaccine. 2012 Aug 4. [Epub ahead of print].

187. Quach S, Pereira JA, Hamid JS, Crowe L, Heidebrecht CL, Kwong JC, Guay M, Crowcroft NS, McGeer A, Chambers LW, Quan SD, Bettinger JA; Public Health Agency  of Canada/Canadian Institutes of Health Research Influenza Research Network PCIRN Vaccine Coverage Theme Group; Canadian Healthcare Influenza Immunization Network. Measuring influenza immunization coverage among health care workers in acute care hospitals and continuing care organizations in Canada. Am J Infect Control. 2012  Aug 15. [Epub ahead of print].

188. Quadri-Sheriff M, Hendrix KS, Downs SM, Sturm LA, Zimet GD, Finnell SM. The  role of herd immunity in parents' decision to vaccinate children: a systematic review. Pediatrics. 2012 Sep; 130(3):522-30.

189. Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, Sztein MB, Pasetti MF. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol. 2012 Aug; 144(2):98-108.

190. Ratanasiripong NT. A Review of Human Papillomavirus (HPV) Infection and HPV  Vaccine-Related Attitudes and Sexual Behaviors Among College-Aged Women in the United States. J Am Coll Health. 2012 Aug; 60(6):461-70.

191. Regan DG. Population benefits of HPV vaccination for boys: a complex equation. Evid Based Med. 2012 Aug; 17(4):118-9.

192. Reynales H, Astudillo P, de Vallière S, Hatz C, Schlagenhauf P, Rath B, Velentgas P, Fariña A, Sales-Carmona V, Groth N. A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012 Aug 15. [Epub ahead of print].

193. Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A. A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine. 2012 Aug 5. [Epub ahead of print].

194. Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; on behalf of the 2001 Study Investigators. Safety, immunogenicity,  and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2012 Aug;12(8):597-607.

195. Roestenberg M, de Vlas SJ, Nieman AE, Sauerwein RW, Hermsen CC. Efficacy of  preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers. J Infect Dis. 2012 Aug; 206(3):319-23.

196. Rowan-Legg A, Barrowman N, Le Saux N, Shenouda N, Koujok K. Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital. BMC Pediatr. 2012 Aug 28; 12(1):133. [Epub ahead of print].

197. Rozenbaum MH, De Vries R, LE HH, Postma MJ. Modelling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiol Infect. 2012 Aug; 140(8):1503-14.

198. Rui LP, Zhang L, Tang N, Wang T. [Analysis of indexes used to evaluate immunization coverage rate of first dose of measles containing vaccine]. Beijing  Da Xue Xue Bao. 2012 Aug 18; 44(4):617-21.

199. Ruijs WL, Hautvast JL, van Ijzendoorn G, van Ansem WJ, Elwyn G, van der Velden K, Hulscher ME. How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Serv Res. 2012 Aug 1; 12(1):231. [Epub ahead of print] PubMed PMID:

200. Salisbury DM. Male vaccination against human papillomavirus. Lancet Infect Dis. 2012 Aug;12(8):582-3.

201. Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients. Transpl Infect Dis. 2012 Aug  13. [Epub ahead of print].

202. Sanderson K. Vaccination: A durable design. Nature. 2012 Aug 30;488(7413):S7.

203. Santos-Ocampo AS. Elevated anti-neutrophil cytoplasmic antibodies without vasculitis after influenza vaccination. J Clin Rheumatol. 2012 Aug;18(5):276-7.

204. Schlecht NF, Rojas M, Lorde-Rollins E, Nucci-Sack A, Strickler HD, Burk RD,  Diaz A. Burden of Cervical, Anal, and Oral HPV in an Inner-City Pre-vaccine Adolescent Population. J Urban Health. 2012 Aug 30. [Epub ahead of print].

205. Schmaljohn CS, Smith LA, Friedlander AM. Military vaccines in today's environment. Hum Vaccin Immunother. 2012 Aug 1;8(8). [Epub ahead of print].

206. Scott LJ, Carter NJ, Curran MP. Live Attenuated Influenza Vaccine (FluenzTM): A Guide to its Use in the Prevention of Seasonal Influenza in Children in the EU. Paediatr Drugs. 2012 Aug 1;14(4):271-9.

207. Seward JF, Orenstein WA. Editorial commentary: a rare event: a measles outbreak in a population with high 2-dose measles vaccine coverage. Clin Infect Dis. 2012 Aug; 55(3):403-5.

208. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, Holland  LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). 2012 Aug; 36(8):1072-7.

209. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak. Clin Infect Dis. 2012 Aug 31. [Epub ahead of print].

210. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012 Aug 1; 308(5):454-6.

211. Shimizu M, Ueno K, Yachie A. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab. Clin Vaccine Immunol. 2012 Aug 8. [Epub ahead of print].

212. Shin J, Kim J, Song K. Influences on formation of tetanus antibody after simultaneous injection of tetanus immunoglobulin with tetanus vaccine. J Korean Med Sci. 2012 Aug; 27(8):934-8.

213. Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R. Serum IgM antibodies contribute to high opsonophagocytic activities in toddlers immunized with a single dose of 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol. 2012 Aug 8. [Epub ahead of print].

214. Simpson CR, McMenamin J. Pandemic influenza vaccination for healthcare workers in primary care: good progress, but higher uptake required. Prim Care Respir J. 2012 Aug 10. [Epub ahead of print].

215. Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, Dionne M, Sabaiduc S, Gardy JL, Li G, Bastien N, Petric M, Boivin G, Li Y. Cross-reactive and vaccine-induced antibody to emerging swine influenza A(H3N2)v. J Infect Dis. 2012 Aug 7. [Epub ahead of print].

216. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, Crowcroft NS, Fradet MD, Bastien N, Li Y, Krajden M, Sabaiduc S, Petric M. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis. 2012 Aug;55(3):332-42.

217. Smit R. Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults. Vaccine. 2012 Aug 9. [Epub ahead of print].

218. Stadlin S, Bednarczyk RA, Omer SB. Medical Exemptions to School Immunization Requirements in the United States--Association of State Policies With Medical Exemption Rates (2004-2011). J Infect Dis. 2012 Aug 29. [Epub ahead of print].

219. Stanley M. Perspective: Vaccinate boys too. Nature. 2012 Aug 30;488(7413):S10.

220. Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock  J, Parker SD, Jacobson RM, Poland GA, McNeil MM. Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 2012 Aug 31;30(40):5875-9.

221. Stoecker C, Hampton LM, Moore MR. 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series. Vaccine. 2012 Aug 17. [Epub ahead of print].

222. Stojanovski K, McWeeney G, Emiroglu N, Ostlin P, Koller T, Licari L, Kaluski DN. Risk factors for low vaccination coverage among Roma children in disadvantaged settlements in Belgrade, Serbia. Vaccine. 2012 Aug 10;30(37):5459-63.

223. Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals. Influenza Other Respi Viruses. 2012 Aug 23. [Epub ahead of print].

224. Strutton DR, Farkouh RA, Rubin JL, McGarry LJ, Loiacono PM, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch up program using United States claims data. BMC Infect Dis. 2012 Aug 3;12:175.

225. Sudarshan S, Huang EH, Lim PL, Leo YS, Lim SA. A case of post-vaccination optic neuritis: coincidence or causative? Eye (Lond). 2012 Aug 10. [Epub ahead of print].

226. Sulsky SI, Luippold R, Garman P, Hughes H, Boyko EJ, Maynard C, Amoroso PJ.  Disability among US Army Veterans vaccinated against anthrax. Vaccine. 2012 Aug 5. [Epub ahead of print].

227. Taylor DN, Treanor JJ, Sheldon EA, Johnson C, Umlauf S, Song L, Kavita U, Liu G, Tussey L, Ozer K, Hofstaetter T, Shaw A. Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine. 2012 Aug 24; 30(39):5761-9.

228. Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sørensen C, Jensen AM,  Heilmann C. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012 Aug 10;30(37):5464-71.

229. Thisyakorn U. ADVASC-New regional initiative supporting transition from dengue vaccine to vaccination in Southeast Asia. Vaccine. 2012 Aug 17; 30(38):5587-8.

230. Tonnis WF, Kersten GF, Frijlink HW, Hinrichs WL, de Boer AH, Amorij JP. Pulmonary Vaccine Delivery: A Realistic Approach? J Aerosol Med Pulm Drug Deliv.  2012 Aug 2. [Epub ahead of print]

231. Truong VA. The pediatric vaccine stockpiling problem. Vaccine. 2012 Aug 5. [Epub ahead of print]

232. Trück J, Lazarus R, Jonsdottir I, Klugman KP, Pollard AJ. Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine programme in older adults at present. Clin Infect  Dis. 2012 Aug 17. [Epub ahead of print].

233. Tuells J. Vaccinology: The name, the concept, the adjectives. Vaccine. 2012  Aug 10;30(37):5491-5.

234. Uzicanin A, Thompson M, Smith P, Chaves SS, Foster L, Dube N, Graitcer S, Jackson R, Ferdinands J, Gargiullo P, Mills D, Monto AS, Shay DK; on behalf of the Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group. Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine. J Infect Dis. 2012 Aug 6. [Epub ahead of print].

235. van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R. Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine. 2012 Aug 31;30(40):5880-5.

236. van der Velden MV, Aichinger G, Pöllabauer EM, Löw-Baselli A, Fritsch S, Benamara K, Kistner O, Müller M, Zeitlinger M, Kollaritsch H, Vesikari T, Ehrlich HJ, Barrett PN. Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1  influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming. Vaccine. 2012 Aug 8. [Epub ahead of print].

237. Vecchiarelli A, Pericolini E, Gabrielli E, Pietrella D. New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges. Front Microbiol. 2012;3:294.

238. Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P,  Launay O, Sebbah R, Moatti JP. Pandemic Influenza (A/H1N1) Vaccine Uptake among French Private General Practitioners: A Cross Sectional Study in 2010. PLoS One.  2012; 7(8):e41837.

239. Wardrope A. Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan. J Med Ethics. 2012 Aug 28. [Epub ahead of print].

240. Weinberg SH, Butchart AT, Davis MM. Size of clinical trials and Introductory prices of prophylactic vaccine series. Hum Vaccin Immunother. 2012 Aug 1;8(8). [Epub ahead of print].

241. Wells CR, Bauch CT. The impact of personal experiences with infection and vaccination on behaviour-incidence dynamics of seasonal influenza. Epidemics. 2012 Aug;4(3):139-51.

242. Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years. Vaccine. 2012 Aug 3;30(36):5437-44.

243. Wicker S, Gottschalk R, Wolff U, Krause G, Rabenau HF. [Influenza vaccination rates in Hessian hospitals]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Aug; 55(8):932-6.

244. Widdice LE, Brown DR, Bernstein DI, Ding L, Patel D, Shew M, Fortenberry JD, Kahn JA. Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose. Arch Pediatr Adolesc Med. 2012 Aug 1;166(8):774-6.

245. Wilby KJ, Werry D. A review of the effect of immunization programs on antimicrobial utilization. Vaccine. 2012 Aug 28. [Epub ahead of print].

246. Williams V, Rousculp MD, Price M, Coles T, Therrien M, Griffin J, Hollis K,  Toback S. Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation. J Sch Nurs. 2012 Aug;28(4):256-67.

247. Woodward C. Vaccinating children against anthrax. CMAJ. 2012 Aug 7;184(11):E577-8.

248. Wooten KG, Wortley PM, Singleton JA, Euler GL. Perceptions matter: Beliefs about influenza vaccine and vaccination behavior among elderly white, black and Hispanic Americans. Vaccine. 2012 Aug 30. [Epub ahead of print].

249. Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW. A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus. PLoS One. 2012;7(8):e42363.

250. Xu R, Luo Y, Chambers C. Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models. Pharmacoepidemiol Drug Saf.  2012 Aug; 21(8):844-50.

251. Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H; Guizhou JE Study Group. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou  province, China. Vaccine. 2012 Aug 10; 30(37):5569-77.

252. Zhang Y, Zang GQ, Tang ZH, Yu YS. Universal varicella vaccination needs to be high on the agenda in China. Rev Inst Med Trop Sao Paulo. 2012 Aug; 54(4):237-8.

253. Zhu FC, Wang JZ, Li XL, Liang ZL, Ge HM, Meng FY, Mao QY, Zhang YT, Zhang ZY, Ji H, Gao F, Guo HJ, Zhu QY, Chu K, Wu X, Li JX, Chen QH, Chen XQ, Zhang WW,  Hu YM, Li L, Li FX, Yao X, Liu P, Wang H, Shen XL. Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants. Pediatr Infect Dis J. 2012 Aug 24. [Epub ahead of print].

254. Zimmerman RK, Wiringa AE, Nowalk MP, Lin CJ, Rousculp MD, Mitgang EA, Lee BY. The Comparative Value of Various Employer-Sponsored Influenza Vaccination Clinics. J Occup Environ Med. 2012 Aug 27. [Epub ahead of print].

[Top]